Trading Day Review: Atyr Pharma Inc (ATYR) Loses Momentum, Closing at 3.57

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

The price of Atyr Pharma Inc (NASDAQ: ATYR) closed at $3.57 in the last session, down -7.51% from day before closing price of $3.86. In other words, the price has decreased by -$7.51 from its previous closing price. On the day, 1.3 million shares were traded. ATYR stock price reached its highest trading level at $3.605 during the session, while it also had its lowest trading level at $3.33.

Ratios:

We take a closer look at ATYR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.

On October 04, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.

On September 05, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $9.Jefferies initiated its Buy rating on September 05, 2024, with a $9 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 24 ’24 when SCHIMMEL PAUL bought 52,300 shares for $1.93 per share. The transaction valued at 101,038 led to the insider holds 413,023 shares of the business.

SCHIMMEL PAUL bought 41,052 shares of ATYR for $71,500 on Jul 22 ’24. The Director now owns 354,075 shares after completing the transaction at $1.74 per share. On Jul 23 ’24, another insider, SCHIMMEL PAUL, who serves as the Director of the company, bought 6,648 shares for $1.82 each. As a result, the insider paid 12,075 and bolstered with 360,723 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 299674368 and an Enterprise Value of 247071392. For the stock, the TTM Price-to-Sale (P/S) ratio is 1302.94 while its Price-to-Book (P/B) ratio in mrq is 4.14. Its current Enterprise Value per Revenue stands at 1051.368 whereas that against EBITDA is -3.669.

Stock Price History:

The Beta on a monthly basis for ATYR is 1.11, which has changed by 1.3393939 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, ATYR has reached a high of $4.22, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 3.80%, while the 200-Day Moving Average is calculated to be 50.39%.

Shares Statistics:

According to the various share statistics, ATYR traded on average about 819.71K shares per day over the past 3-months and 552320 shares per day over the past 10 days. A total of 83.94M shares are outstanding, with a floating share count of 81.96M. Insiders hold about 2.36% of the company’s shares, while institutions hold 63.08% stake in the company. Shares short for ATYR as of 1736899200 were 3515857 with a Short Ratio of 4.29, compared to 1734048000 on 2920070. Therefore, it implies a Short% of Shares Outstanding of 3515857 and a Short% of Float of 5.510000000000001.

Most Popular